(Q34321590)

English

Cost-effectiveness of dabigatran versus genotype-guided management of warfarin therapy for stroke prevention in patients with atrial fibrillation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22745801%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Cost-effectiveness of dabigatran versus genotype-guided management of warfarin therapy for stroke prevention in patients with atrial fibrillation (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22745801%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

cost-effectiveness analysis

1 reference

based on heuristic

inferred from title

atrial fibrillation

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22745801%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Raymond Siu-Ming Wong

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22745801%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Kia K N Tsui

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22745801%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Gergory Cheng

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22745801%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

language of work or name

0 references

publication date

22 June 2012

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22745801%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22745801%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22745801%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22745801%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

e39640

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22745801%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

copyright license

Creative Commons Attribution 4.0 International

22 June 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Pharmacoeconomic evaluation of warfarin pharmacogenomics.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382133

6 July 2018

Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382133

6 July 2018

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382133

6 July 2018

National patterns of risk-standardized mortality and readmission for acute myocardial infarction and heart failure. Update on publicly reported outcomes measures based on the 2010 release

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382133

6 July 2018

Warfarin dosing algorithm using clinical, demographic and pharmacogenetic data from Chinese patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382133

6 July 2018

Dabigatran versus warfarin in patients with atrial fibrillation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382133

6 July 2018

Estimation of the warfarin dose with clinical and pharmacogenetic data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382133

6 July 2018

Long-term economic outcomes associated with intensive versus moderate lipid-lowering therapy in coronary artery disease: results from the Treating to New Targets (TNT) Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382133

6 July 2018

Helicobacter pylori test and treat versus proton pump inhibitor in initial management of dyspepsia in primary care: multicentre randomised controlled trial (MRC-CUBE trial).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382133

6 July 2018

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382133

6 July 2018

Death and disability from warfarin-associated intracranial and extracranial hemorrhages

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382133

6 July 2018

Management of Chinese patients on warfarin therapy in two models of anticoagulation service - a prospective randomized trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382133

6 July 2018

Preference-Based EQ-5D index scores for chronic conditions in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382133

6 July 2018

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382133

6 July 2018

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382133

6 July 2018

Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate-intensity anticoagulation?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382133

6 July 2018

Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382133

6 July 2018

Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382133

6 July 2018

Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382133

6 July 2018

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382133

6 July 2018

Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382133

6 July 2018

Decision analysis and guidelines for anticoagulant therapy to prevent stroke in patients with atrial fibrillation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382133

6 July 2018

Recommendations of the Panel on Cost-effectiveness in Health and Medicine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382133

6 July 2018

Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0039640

21 January 2018

Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0039640

21 January 2018

Cost-effectiveness of using pharmacogenetic information in warfarin dosing for patients with nonvalvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0039640

21 January 2018

Potential clinical and economic outcomes of CYP2C9 and VKORC1 genotype-guided dosing in patients starting warfarin therapy.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0039640

21 January 2018

Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness study).

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0039640

21 January 2018

Effect of aspirin and warfarin on early survival after intracerebral haemorrhage

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0039640

21 January 2018

The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0039640

21 January 2018

Cost-effectiveness of pravastatin therapy for survivors of myocardial infarction with average cholesterol levels

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0039640

21 January 2018

Quality of anticoagulation control and costs of monitoring warfarin therapy among patients with atrial fibrillation in clinic settings: a multi-site managed-care study

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0039640

21 January 2018

Comparison of assay systems for warfarin-related CYP2C9 and VKORC1 genotyping

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0039640

21 January 2018

Dabigatran association with higher risk of acute coronary events: meta-analysis of noninferiority randomized controlled trials

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0039640

21 January 2018

Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: a Canadian payer perspective.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0039640

21 January 2018

Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial

2 references

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0039640

21 January 2018

https://pubmed.ncbi.nlm.nih.gov/22745801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Newly identified events in the RE-LY trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22745801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life

1 reference

https://pubmed.ncbi.nlm.nih.gov/22745801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22745801

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0039640

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22745801%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

2012PLoSO...739640Y

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22745801%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22745801%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34321590&oldid=1867103101"